Chemed Corporation CHE
Dividend Power Score
A single, comprehensive score designed to measure the true strength of a company’s dividend.
This score combines three essential pillars of dividend quality:
Consistency – Measures how reliable the dividend has been over time, focusing on payment history, stability, and the absence of cuts or suspensions.
Payability – Assesses the company’s financial ability to sustain its dividend, taking into account cash flow, earnings coverage, balance sheet strength, and overall financial health.
Growth – Evaluates the long-term growth of both the dividend and the company’s share price, highlighting businesses that consistently increase payouts while creating shareholder value.
Higher scores identify companies that have historically delivered dependable income alongside sustained dividend growth and long-term capital appreciation.
Ask Irving AI About CHE
Get to know the stock you’re researching through a simple conversation. Ask Irving about its Weiss rating, financial health, dividends, and potential risks — right from the stock page.
Get answers about this stock. Instantly.
Ask about the company’s financial health and its Weiss Safety, Reward, and Risk Ratings, with answers grounded in Weiss Ratings data.
Understand the numbers behind the rating.
Explore profits, cash flow, valuation, and dividends. Ask follow-up questions without leaving the stock page.
Put the stock’s strengths and risks in context.
Look beyond a single number. Explore rating changes and company trends to better understand the stock’s outlook.
Company Overview
Chemed Corporation (NYSE: CHE) is a diversified healthcare and service company headquartered in Cincinnati, Ohio. The company operates primarily through two wholly owned subsidiaries: VITAS Healthcare Corporation, which provides hospice and palliative care services, and Roto-Rooter Group, Inc., which delivers plumbing, drain cleaning, water restoration, and related maintenance services. Chemed operates in the healthcare services and residential/commercial infrastructure services industries, with revenue primarily generated from patient care reimbursements and service-based repair and maintenance work. Public filings and investor materials consistently identify these two subsidiaries as the company’s core operating platforms.
The company’s primary customer base includes Medicare and Medicaid beneficiaries requiring end-of-life care through VITAS, along with residential homeowners, commercial businesses, and municipalities served by Roto-Rooter. Chemed’s strategic positioning is supported by the scale and brand recognition of both subsidiaries, recurring demand characteristics, and broad geographic coverage across the United States. Chemed traces its roots to the 1970s and evolved through acquisitions and divestitures into its current dual-business structure, with VITAS acquired in 2004 becoming a major healthcare revenue driver alongside the long-established Roto-Rooter franchise business.
Business Operations
Chemed generates substantially all revenue through its two reportable segments: VITAS and Roto-Rooter. VITAS provides hospice care, palliative care, physician services, and related healthcare support primarily to terminally ill patients. Revenue is largely derived from Medicare reimbursement programs, supplemented by Medicaid and private insurance payments. Roto-Rooter generates revenue through plumbing repair, drain cleaning, excavation, water restoration, and related emergency services delivered through company-owned branches and independent contractor franchise operations. Both segments are predominantly U.S.-based, though Roto-Rooter maintains select international franchise operations.
The company controls significant operational infrastructure, including healthcare service networks, call centers, dispatch systems, branded service fleets, and franchise relationships. Roto-Rooter benefits from strong consumer brand recognition and a broad technician network, while VITAS maintains extensive clinical operations and hospice certifications across multiple states. Chemed’s operations are supported by centralized corporate oversight and capital allocation practices disclosed in annual reports and filings such as the company’s Form 10-K and quarterly Form 10-Q submissions.
Strategic Position & Investments
Chemed’s strategic direction has focused on disciplined capital allocation, operational efficiency, and selective expansion within healthcare and service markets. In recent years, VITAS has emphasized census growth, expansion into new hospice markets, and investments in clinical capabilities and compliance infrastructure. Roto-Rooter has continued investing in branch expansion, technician recruitment, digital customer acquisition, and water restoration services, which have become a larger contributor to segment growth.
The company has historically pursued targeted acquisitions that strengthen local market density and operational scale, particularly within hospice care and plumbing service territories. Chemed has also maintained active share repurchase programs and dividend distributions, reflecting a shareholder-return-oriented capital strategy. Public disclosures indicate continued investment in technology systems, operational analytics, dispatch optimization, and workforce management tools across both subsidiaries. No major diversification outside its two core business lines has been prominently disclosed in recent public filings.
Geographic Footprint
Chemed operates primarily within the United States, where both VITAS and Roto-Rooter maintain extensive national coverage. VITAS provides hospice and palliative care services across numerous U.S. states, with concentrations in large metropolitan markets and regions with significant aging populations. Roto-Rooter maintains company-owned service branches and franchise operations throughout the U.S., supporting both residential and commercial customers.
International exposure is limited compared with domestic operations, though Roto-Rooter has franchise operations in Canada and select additional international markets. Chemed’s corporate headquarters are located in Cincinnati, Ohio, while operational infrastructure is distributed nationwide through regional offices, service centers, and clinical locations. Public filings consistently characterize the company as predominantly U.S.-focused in terms of revenue generation and operational concentration.
Leadership & Governance
Chemed’s leadership structure combines centralized corporate governance with operational autonomy at the subsidiary level. The company emphasizes disciplined management, long-term capital allocation, operational accountability, and decentralized execution through its two major operating businesses. Governance practices and executive compensation structures are detailed in annual proxy filings and SEC disclosures.
Key executives include:
- Kevin J. McNamara – President and Chief Executive Officer
- Michael D. Witzeman – Vice President and Chief Financial Officer
- Spencer S. Lee – President and Chief Operating Officer of Roto-Rooter
- Nicholas M. Westfall – Chairman and Chief Executive Officer of VITAS Healthcare
- Arthur V. Tucker, Jr. – Executive Vice President and Chief Legal Officer
Leadership communications in investor presentations and annual reports emphasize sustainable cash flow generation, disciplined acquisition evaluation, regulatory compliance, and maintaining market leadership positions within hospice care and plumbing services.